Loading…
Dual-specificity Phosphatase 1 Deficiency Induces Endometrioid Adenocarcinoma Progression via Activation of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Pathway
Background: Previously, we reported that dual-specificity adenocarcinoma (EEA). However, the role of DUSP1 medroxyprogesterone (MPA) are still unclear. phosphatase I (DUSPI) was differentially expressed in endometrioid in EEA progression and the relationship between DUSPI and Methods: The expression...
Saved in:
Published in: | Chinese medical journal 2016-05, Vol.129 (10), p.1154-1160 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: Previously, we reported that dual-specificity adenocarcinoma (EEA). However, the role of DUSP1 medroxyprogesterone (MPA) are still unclear. phosphatase I (DUSPI) was differentially expressed in endometrioid in EEA progression and the relationship between DUSPI and Methods: The expression of DUSPI in EEA specimens was detected by immunohistochemical analysis. The effect of DUSPI on cell proliferation was analyzed by Cell Counting Kit 8 and colony formation assay, and cell migration was analyzed by transwell assay. MPA-induced DUSPI expression in EEA cells was measured by Western blot. Results: DUSPI expression was deficient in advanced International Federation of Gynecology and Obstetrics stage, high-grade and myometrial invasive EEA. In EEA cell lines (HeclA, Hecl B, RL952, and Ishikawa), the DUSP1 expression was substantially higher in lshikawa cells than in other cell lines (P 〈 0.05). Knockdown ofDUSP I promoted lshikawa cells proliferation, migration, and activation of mitogen-activated protein kinases/extracellular signal-regulated kinase (MAPK/Erk) pathway. MPA-induced DUSP1 expression and inhibited MAPK/Erk pathway in Ishikawa cells. Conclusions: Our data suggest that DUSP1 deficiency promotes EEA progression via MAPK/Erk pathway, which may be reversed by MPA, suggesting that DUSP I may serve as a potential therapeutic target for the treatment of EEA. |
---|---|
ISSN: | 0366-6999 2542-5641 |
DOI: | 10.4103/0366-6999.181954 |